BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 6, 2013
Insider Transaction Report
Form 4
Morgan Henry
Director
Transactions
- Sale
Common Stock, $0.001 par value
2013-09-04$18.55/sh−5,000$92,750→ 25,043 total - Sale
Common Stock, $0.001 par value
2013-09-04$18.50/sh−5,000$92,500→ 30,043 total - Sale
Common Stock, $0.001 par value
2013-09-04$18.60/sh−2,402$44,677→ 22,641 total - Sale
Common Stock, $0.001 par value
2013-09-05$18.35/sh−5,448$99,971→ 17,193 total
Footnotes (4)
- [F1]Selling price of $18.50 is reflective of the weighted average sale price of all transactions reported on this line.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.55 to $18.56. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Selling price of $18.60 is reflective of the weighted average sale price of all transactions reported on this line.
- [F4]Selling price of $18.35 is reflective of the weighted average sale price of all transactions reported on this line.